Daniel Rudeklint

Daniel Rudeklint

Chief Executive Officer at EMOTRA AB (PUBL)
45 year
Health Technology
Consumer Services
Electronic Technology

Profile

Daniel Rudeklint currently works at Globopetz AB, as President, Chief Executive Officer, CFO & Director from 2022, Peptonic Medical AB, as Chief Executive Officer & Director from 2026, Petslovesurprises AB, as Chairman from 2023, Wonderboo Holding AB, as Independent Director from 2022, C100 AB, as Director from 2025, Vaxxa AB, as Director from 2023, and ASTGW AB, as Director from 2022.
Mr. Rudeklint also formerly worked at KebNi AB, as Director from 2022 to 2024.
Mr. Rudeklint received his graduate degree from Luleå University of Technology.

Daniel Rudeklint active positions

CompaniesPositionStart
EMOTRA AB (PUBL) Chief Executive Officer 2021-10-31
PEPTONIC MEDICAL AB Chief Executive Officer 2026-02-25
WONDERBOO HOLDING AB Director/Board Member 2021-12-31
VULTUS AB Director/Board Member 2025-05-31
VAXXA AB Director/Board Member 2022-12-31
ASTGW AB
Director/Board Member 2021-12-31

Former positions of Daniel Rudeklint

CompaniesPositionEnd
KEBNI AB Director/Board Member 2024-04-30
See the detail of Daniel Rudeklint's experience

Training of Daniel Rudeklint

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Health Technology

Health Technology

Electronic Technology

Communications

ASTGW AB

Retail Trade

Consumer Non-Durables

  1. Stock Market
  2. Insiders
  3. Daniel Rudeklint